GENOCEA BIOSCIENCES, INC. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOCEA BIOSCIENCES, INC. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Sonsini Peter W. | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Chang Carmen | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BASKETT FOREST | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BARRIS PETER J | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.54 | 750,000 | 405,000 | 750,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Alfieri Michael | Principle Financial ... | Option Exercise | A | 0.54 | 75,000 | 40,500 | 75,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Meisner Derek M | SENIOR VP AND GENER ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Carroll Pamela | SVP IMMUNO-ONCOLOGY | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Singh Narinderjeet | SENIOR VP, PS&M | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.54 | 750,000 | 405,000 | 750,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Alfieri Michael | Principle Financial ... | Option Exercise | A | 0.54 | 75,000 | 40,500 | 75,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Meisner Derek M | SENIOR VP AND GENER ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 0.54 | 350,000 | 189,000 | 350,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Carroll Pamela | SVP IMMUNO-ONCOLOGY | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 |